{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:13:16Z","timestamp":1792131196176,"version":"4.4.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Global Dengue and Aedes-Transmitted Diseases Consortium"},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001869"],"award-info":[{"award-number":["MOH-001869"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001271-00"],"award-info":[{"award-number":["MOH-001271-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001290"],"award-info":[{"award-number":["MOH-001290"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>\n                    On 12th June 2025, Duke-NUS Medical School, supported by the Global Dengue and\n                    <jats:italic>Aedes<\/jats:italic>\n                    -Transmitted Diseases Consortium (GDAC), hosted a one-day symposium in Singapore titled\n                    <jats:italic>\u201cChallenging the norm: Accelerating dengue countermeasures through human challenge studies\u201d.<\/jats:italic>\n                    Comprising sessions on both dengue and other viral infection models, the symposium explored how human challenge studies could address gaps in dengue pathogenesis and immunity to inform vaccine development and application. Keynote speakers highlighted persistent challenges in dengue vaccine development, including incomplete protection across all four dengue viruses, complexities in dengue immunity, and past safety concerns that have influenced regulatory pathways. Case studies from Thailand and Bangladesh illustrated the feasibility and safety of dengue challenge studies in endemic settings. Parallel discussions drew lessons from human infection models of SARS-CoV-2 and other respiratory viruses that are directly relevant to expanding the use of dengue human challenge studies. Sessions on public engagement and regulatory frameworks emphasised the importance of trust, transparent communication, and harmonisation in the design, conduct, and acceptance of challenge studies. Overall, the symposium highlighted that human challenge studies, if implemented thoughtfully, can advance dengue vaccine research, accelerate clinical evaluation and regulatory approval of vaccine candidates, and support evidence-based public health strategies to strengthen global dengue control efforts.\n                  <\/jats:p>","DOI":"10.1371\/journal.pntd.0013889","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:22:22Z","timestamp":1767982942000},"page":"e0013889","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proceedings of the inaugural symposium on dengue human challenge studies \u201cChallenging the norm: Accelerating dengue countermeasures through human studies\u201d"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9319-5908","authenticated-orcid":true,"given":"Shirin","family":"Kalimuddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Waickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panisadee","family":"Avirutnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shafiul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby E.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra C.","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K.","family":"Pakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne","family":"Manski-Nankervis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pengilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cavaleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert I.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Eong","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"4","key":"pntd.0013889.ref001","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00244-24","article-title":"Dengue and severe dengue","volume":"38","author":"S Kalimuddin","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"pntd.0013889.ref002","doi-asserted-by":"crossref","first-page":"107940","DOI":"10.1016\/j.ijid.2025.107940","article-title":"Global dengue epidemic worsens with record 14 million cases and 9000 deaths reported in 2024","volume":"158","author":"N Haider","year":"2025","journal-title":"Int J Infect Dis"},{"issue":"1","key":"pntd.0013889.ref003","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-023-00658-2","article-title":"Is new dengue vaccine efficacy data a relief or cause for concern?","volume":"8","author":"SJ Thomas","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"704","key":"pntd.0013889.ref004","article-title":"Insights into dengue immunity from vaccine trials","volume":"15","author":"EE Ooi","year":"2023","journal-title":"Sci Transl Med"},{"issue":"5","key":"pntd.0013889.ref005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMoa2301790","article-title":"Live, attenuated, tetravalent butantan-dengue vaccine in children and adults","volume":"390","author":"EG Kall\u00e1s","year":"2024","journal-title":"N Engl J Med"},{"issue":"10234","key":"pntd.0013889.ref006","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial","volume":"395","author":"S Biswal","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"pntd.0013889.ref007","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"S Sridhar","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"pntd.0013889.ref008","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2105\/AJPH.2016.303113","article-title":"The epidemic of Zika virus-related microcephaly in brazil: detection, control, etiology, and future scenarios","volume":"106","author":"MG Teixeira","year":"2016","journal-title":"Am J Public Health"},{"issue":"10","key":"pntd.0013889.ref009","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M16-0332","article-title":"Emergence of congenital Zika syndrome: viewpoint from the front lines","volume":"164","author":"F Costa","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"pntd.0013889.ref010","doi-asserted-by":"crossref","first-page":"108226","DOI":"10.1016\/j.celrep.2020.108226","article-title":"Antigenic variation of the dengue virus 2 genotypes impacts the neutralization activity of human antibodies in vaccinees","volume":"33","author":"DR Martinez","year":"2020","journal-title":"Cell Rep"},{"key":"pntd.0013889.ref011","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0113-2024","article-title":"The greatest dengue epidemic in Brazil: surveillance, prevention, and control","volume":"57","author":"R Gurgel-Gon\u00e7alves","year":"2024","journal-title":"Rev Soc Bras Med Trop"},{"key":"pntd.0013889.ref012","article-title":"Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in S\u00e3o Paulo, Brazil: a test-negative, case-control study","author":"OT Ranzani","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pntd.0013889.ref013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13063-022-05997-4","article-title":"EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil","volume":"23","author":"MH Collins","year":"2022","journal-title":"Trials"},{"key":"pntd.0013889.ref014","first-page":"37","article-title":"The etiology of yellow fever: a preliminary note","volume":"26","author":"W Reed","year":"1900","journal-title":"Public Health Pap Rep"},{"issue":"1","key":"pntd.0013889.ref015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"AB Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"pntd.0013889.ref016","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4269\/ajtmh.14-0132","article-title":"Review article: research on dengue during World War II revisited","volume":"91","author":"GE Snow","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"50","key":"pntd.0013889.ref017","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1016\/j.vaccine.2015.09.052","article-title":"Dengue human infection models to advance dengue vaccine development","volume":"33","author":"CP Larsen","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"pntd.0013889.ref018","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1038\/s41467-021-22930-6","article-title":"Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model","volume":"12","author":"JP Hanley","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"pntd.0013889.ref019","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173328","article-title":"TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies","volume":"134","author":"KK Pierce","year":"2024","journal-title":"J Clin Invest"},{"issue":"5","key":"pntd.0013889.ref020","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/infdis\/jis744","article-title":"Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines","volume":"207","author":"W Sun","year":"2013","journal-title":"J Infect Dis"},{"key":"pntd.0013889.ref021","article-title":"The human dengue challenge experience at the Walter Reed Army Institute of Research","author":"AG Lyons","year":"2014","journal-title":"J Infect Dis"},{"issue":"2","key":"pntd.0013889.ref022","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jiaa351","article-title":"A phase 1, open-label assessment of a dengue virus-1 live virus human challenge strain","volume":"223","author":"TP Endy","year":"2021","journal-title":"J Infect Dis"},{"issue":"5","key":"pntd.0013889.ref023","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/s41564-024-01668-z","article-title":"Low-dose dengue virus 3 human challenge model: a phase 1 open-label study","volume":"9","author":"AT Waickman","year":"2024","journal-title":"Nat Microbiol"},{"issue":"8","key":"pntd.0013889.ref024","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S1473-3099(24)00100-2","article-title":"Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial","volume":"24","author":"KE Lyke","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"330","key":"pntd.0013889.ref025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"BD Kirkpatrick","year":"2016","journal-title":"Sci Transl Med"},{"issue":"21","key":"pntd.0013889.ref026","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa2500179","article-title":"Daily mosnodenvir as dengue prophylaxis in a controlled human infection model","volume":"393","author":"AP Durbin","year":"2025","journal-title":"N Engl J Med"},{"issue":"749","key":"pntd.0013889.ref027","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn2199","article-title":"Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1","volume":"16","author":"JV Zambrana","year":"2024","journal-title":"Sci Transl Med"},{"issue":"814","key":"pntd.0013889.ref028","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ads9572","article-title":"Dengue disease severity in humans is augmented by waning Japanese encephalitis virus immunity","volume":"17","author":"S Malhotra","year":"2025","journal-title":"Sci Transl Med"},{"issue":"2","key":"pntd.0013889.ref029","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae066","article-title":"The epidemiologic and clinical characteristics of the 2023 dengue outbreak in Bangladesh","volume":"11","author":"N Sharif","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"pntd.0013889.ref030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1473-3099(23)00520-0","article-title":"Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial","volume":"24","author":"M-CR Walsh","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"pntd.0013889.ref031","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1473-3099(11)70142-6","article-title":"Potential role of human challenge studies for investigation of influenza transmission","volume":"11","author":"B Killingley","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"8019","key":"pntd.0013889.ref032","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-024-07575-x","article-title":"Human SARS-CoV-2 challenge uncovers local and systemic response dynamics","volume":"631","author":"RGH Lindeboom","year":"2024","journal-title":"Nature"},{"issue":"11","key":"pntd.0013889.ref033","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMp2106970","article-title":"SARS-CoV-2 human challenge studies\u2014establishing the model during an evolving pandemic","volume":"385","author":"G Rapeport","year":"2021","journal-title":"N Engl J Med"},{"issue":"6513","key":"pntd.0013889.ref034","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba9301","article-title":"Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection","volume":"370","author":"MS Habibi","year":"2020","journal-title":"Science"},{"issue":"7","key":"pntd.0013889.ref035","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1164\/rccm.202103-0620OC","article-title":"Innate-like gene expression of lung-resident memory CD8+ T cells during experimental human influenza: a clinical study","volume":"204","author":"S Paterson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pntd.0013889.ref036","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41591-022-01780-9","article-title":"Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults","volume":"28","author":"B Killingley","year":"2022","journal-title":"Nat Med"},{"issue":"3","key":"pntd.0013889.ref037","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2009.07.006","article-title":"Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans","volume":"6","author":"AK Zaas","year":"2009","journal-title":"Cell Host Microbe"},{"key":"pntd.0013889.ref038","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3389\/fimmu.2017.01839","article-title":"Transcriptomics in human challenge models","volume":"8","author":"AJ Barton","year":"2017","journal-title":"Front Immunol"},{"issue":"322","key":"pntd.0013889.ref039","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad6873","article-title":"Host gene expression classifiers diagnose acute respiratory illness etiology","volume":"8","author":"EL Tsalik","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"pntd.0013889.ref040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052198","article-title":"A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2","volume":"8","author":"CW Woods","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"pntd.0013889.ref041","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciw145","article-title":"Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor","volume":"62","author":"WH Chen","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:22:28Z","timestamp":1767982948000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013889"}},"subtitle":[],"editor":[{"given":"David J.","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013889","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}